美因基因有限公司（股票代码：06667）于2026年2月2日发布截至2026年1月31日的股份变动月报表。报告显示，公司注册股本维持在500,000,000股，面值每股0.0001美元，法定股本总额约50,000美元，较上月无任何变化。
公司已发行普通股数量仍为224,300,200股，期间无新增发行、回购或注销活动，亦无库藏股持有，股本结构保持稳定，符合香港联交所的公眾持股量要求。
报告显示无任何股份期权、可换股票据或其他股权激励计划的变动记录。公司确认遵守香港联交所《上市规则》及相关法律规定。该公告由董事姜晶签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.